10 min listen
ACCEL Lite: AHA Late-Breaker: PROGRESSIVE-AF – The Impact of “First-Line” Rhythm Therapy on Atrial Fibrillation Progression
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ACCEL Lite: AHA Late-Breaker: PROGRESSIVE-AF – The Impact of “First-Line” Rhythm Therapy on Atrial Fibrillation Progression
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ratings:
Length:
8 minutes
Released:
Jan 31, 2023
Format:
Podcast episode
Description
The drug treatments we use to manage atrial fibrillation don't change the progression in the disease. Catheter ablation, even when performed in younger and healthier patients, modifies the disease trajectory and prevents progression. In this interview, Jason G. Andrade MD, FRCPC and Christopher M. Kramer MD, FACC discuss AHA Late-Breaker: PROGRESSIVE-AF – The Impact of “First-Line” Rhythm Therapy on Atrial Fibrillation Progression. Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
Released:
Jan 31, 2023
Format:
Podcast episode
Titles in the series (100)
ACCEL Lite: Asymptomatic Severe AS; Outcomes of Early Intervention: In this interview, Spencer King III, MD, MACC; Michael Reardon, MD; and Michelle Kelsey, MD, discuss the natural history of asymptomatic severe aortic stenosis and the association of early intervention with outcomes. For 20+ insider interviews like... by ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research